CSBR
Champions Oncology Inc

1,023
Loading...
Loading...
News
all
press releases
Craig-Hallum Sticks to Its Buy Rating for Champions Oncology (CSBR)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Champions Oncology (CSBR Research Report). The company's sha...
TipRanks Financial Blog·1y ago
News Placeholder
More News
News Placeholder
Champions Oncology Third Quarter 2024 Earnings: US$0.19 loss per share (vs US$0.18 loss in 3Q 2023)
Champions Oncology ( NASDAQ:CSBR ) Third Quarter 2024 Results Key Financial Results Revenue: US$12.0m (down 5.9% from...
Simply Wall St·1y ago
News Placeholder
Craig-Hallum gets more bearish on Champions Oncology, downgrades shares
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript
Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript...
SeekingAlpha·2y ago
News Placeholder
Champions Oncology Non-GAAP EPS of -$0.16, revenue of $12M
Champions Oncology Non-GAAP EPS of -$0.16, revenue of $12M...
SeekingAlpha.com: All News·2y ago
News Placeholder
Champions Oncology: Q3 Earnings Insights
read more...
Benzinga·2y ago
News Placeholder
Champions Oncology Reports Quarterly Revenue of $12.0 Million
HACKENSACK, NJ / ACCESSWIRE / March 12, 2024 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today...
Accesswire·2y ago
News Placeholder
Avance: ganancias de Champions Oncology
Champions Oncology (NASDAQ:CSBR) publica su pr xima ronda de ganancias este martes, 12 de marzo. Esta es la gu a esencial de Benzinga para el informe de ganancias del tercer trimestre de Champions...
Benzinga·2y ago
News Placeholder
Anteprima degli utili: Champions Oncology
Champions Oncology (NASDAQ:CSBR) pubblicher i prossimi risultati degli utili questo marted 12 marzo. Per tutte le informazioni in merito, ecco la tua guida sulla pubblicazione degli utili di marted...
Benzinga·2y ago
News Placeholder
Craig-Hallum Gives a Buy Rating to Champions Oncology (CSBR)
Craig-Hallum analyst Matt Hewitt assigned a Buy rating to the stock today. The company's shares closed yesterday at $5.61. According to TipRanks, H...
TipRanks Financial Blog·2y ago

Latest CSBR News

View

Advertisement. Remove ads.

Advertisement. Remove ads.